Majority of hospitalized patients with advanced cancer have functional impairment

New research from Mass General Cancer Center, published in the June 2020 issue of JNCCN--Journal of the National Comprehensive Cancer Network, found 40.2% of hospitalized patients with advanced, incurable cancer were functionally impaired at the time of admission, meaning they needed assistance with activities of daily living (ADLs) like walking, bathing, getting dressed, or other routine tasks. Patients with functional impairment also had higher rates of pain, depression, and anxiety, and were more likely to have longer hospital stays and worse survival.

Interventions addressing patients' functional impairment and symptom management could help enhance care delivery and outcomes for the highly symptomatic population of hospitalized patients with advanced cancer.

This highlights the need for efforts to integrate functional assessments into the care of these patients to identify individuals who may benefit from physical therapy, palliative care, and/or other supportive services earlier in their hospital stay.

Our finding that individuals with functional impairment experience worse survival could also help guide conversations about goals of care and hospice planning among hospitalized patients with cancer."

Daniel E. Lage, MD, MsC, Lead Researcher, Mass General Cancer Center.

"We are also actively exploring interventions to help patients transition from the inpatient to the outpatient setting, which we have identified as a key challenge for patients with functional impairment," added senior researcher Ryan D. Nipp, MD, MPH, Mass General Cancer Center.

"Future work is needed to develop novel models of care to enhance access to palliative care services and address barriers that limit appropriate access to palliative care among patients with advanced cancer."

The researchers studied 970 patients age 18-and-older with advanced cancer--defined as those not being treated with curative intent--who experienced an unplanned hospital admission at Mass General Cancer Center between September 2, 2014 and March 31, 2016.

They measured functional impairment using nursing documentation collected at intake and stored in electronic health records (EHR), and also collected self-completed questionnaires from the patients. ADL impairment was defined as any need for assistance by another person.

Overall, 390 patients (40.2%) had at least one ADL impairment with 14.8% having one or two, and 25.4% experiencing at least three areas of difficulty with daily tasks.

"Oncologists have long appreciated that functional status is a powerful predictor of a number of important outcomes including survival and treatment outcomes," commented Toby Campbell, MD, Chief of Palliative Care at the University of Wisconsin Carbone Cancer Center, who was not involved in this research.

"We know that the routine assessment of symptom burden and functional status in the outpatient setting results in improved survival and quality of life."

Dr. Campbell, a Member of the NCCN Guidelines® Panel for Palliative Care, continued: "Dr. Lage and colleagues highlight the important, often-missed, opportunity to routinely use hospitalization as a trigger for a careful assessment of symptoms and functional status.

"An unplanned hospitalization for an advanced cancer patient is a watershed moment and predicts higher symptoms and shorter survival in patients with and without impaired function. Hospitalization is a crucial opportunity to facilitate critical serious illness care, including comprehensive palliative care and advanced care planning, with the promise of improving the lives of our patients."

Source:
Journal reference:

Lage, D. E., et al. (2020) Functional Impairment, Symptom Burden, and Clinical Outcomes Among Hospitalized Patients With Advanced Cancer. Journal of the National Comprehensive Cancer Network. doi.org/10.6004/jnccn.2019.7385.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FarrSight-Twin technology transforms cancer treatment research